Mahmood Asim, Lu Dunyue, Wang Lei, Chopp Michael
Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan 48202, USA.
J Neurotrauma. 2002 Dec;19(12):1609-17. doi: 10.1089/089771502762300265.
This study was designed to examine the effects of bone marrow stromal cells (MSCs) cultured in vitro with or without neurotrophic factors transplanted into adult male Wistar rats after traumatic brain injury (TBI). MSCs harvested from donor Wistar rats were cultured with either the culture medium containing brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) or the same culture media without these factors. Control and experimental animals were then traumatized by a controlled cortical impact. One day after the impact, either the placebo or the washed MSCs (1 x 10(6)) cultured with or without NGF and BDNF were transplanted adjacent to the site of injury. In addition, a nontreated group of rats was employed. Motor function of the animals was evaluated by the Rotarod test both before and after the injury. All animals were sacrificed 8 days after TBI, and the brain sections were stained by H&E as well as for immunohistochemistry. MSCs survived and migrated toward the injury site. The group treated with MSCs cultured with BDNF and NGF had a significantly higher number of engrafted cells than the group treated with MSCs cultured without BDNF and NGF (6.3 x 10(4) +/- 4250 compared to 4.1 x 10(4) +/- 3684; p < 0.05). In both groups, some transplanted MSCs showed positive staining for astrocytic (GFAP) and neuronal markers (Neu N and MAP-2). The groups treated with MSCs had better motor function than the groups receiving no treatment or receiving the placebo (PBS; p < 0.05); however, the improvement reached statistical significance only in the group treated with MSCs cultured with neurotrophic factors. These data suggest that more robust motor function described in rats subjected to TBI and treated with intracerebral transplantation of MSCs was achieved by the use of MSCs cultured with neurotrophic factors.
本研究旨在探讨体外培养的骨髓基质细胞(MSCs)在添加或不添加神经营养因子的情况下,移植到成年雄性Wistar大鼠创伤性脑损伤(TBI)后所产生的影响。从供体Wistar大鼠获取的MSCs,分别在含有脑源性神经营养因子(BDNF)和神经生长因子(NGF)的培养基中,以及不含这些因子的相同培养基中进行培养。然后,通过控制性皮质撞击对对照动物和实验动物造成创伤。撞击后一天,将安慰剂或经洗涤的MSCs(1×10⁶)(无论是否添加NGF和BDNF进行培养)移植到损伤部位附近。此外,还设立了一组未处理的大鼠。在损伤前后,通过转棒试验评估动物的运动功能。所有动物在TBI后8天处死,脑切片进行苏木精-伊红(H&E)染色以及免疫组织化学染色。MSCs存活并向损伤部位迁移。与未添加BDNF和NGF培养的MSCs处理组相比,添加BDNF和NGF培养的MSCs处理组植入细胞数量显著更多(分别为6.3×10⁴±4250和4.1×10⁴±3684;p<0.05)。在两组中,一些移植的MSCs对星形胶质细胞标记物(胶质纤维酸性蛋白,GFAP)和神经元标记物(神经元核抗原,Neu N和微管相关蛋白2,MAP-2)呈阳性染色。接受MSCs治疗的组比未接受治疗或接受安慰剂(磷酸盐缓冲液,PBS)治疗的组具有更好的运动功能(p<0.05);然而,仅在添加神经营养因子培养的MSCs治疗组中,运动功能的改善达到统计学显著水平。这些数据表明,通过使用添加神经营养因子培养的MSCs对TBI大鼠进行脑内移植,可实现更显著的运动功能改善。